Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OC000459 in mild to moderate asthma
NCT01057927Phase 2Completed
- Sponsor
- Oxagen
- Start
- Jan 2007
- Primary completion
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of timapiprant in asthma, sponsored by Oxagen. Started Jan 2007; status: completed.
02
Drugs
timapiprant
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01057927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01057927.